Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
geriatric-medicines-market

Geriatric Medicines Market [By Therapeutic Category (Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant); By Therapeutic Conditions (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory); and by Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2018 – 2026

Published: Jul 2018
Pages: 110
Format: PDF
Report ID: PM1338
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The worldwide Geriatric Medicines Market was estimated at USD 613.97 billion in 2017 and is anticipated to gain significant traction over coming years.

Geriatric medicines, also known as geriatrics is a specialty field which focuses on health care of the geriatric population. This area targets to improve the elderly people’s health by treating and preventing disabilities and diseases. In general, the geriatrics population is not capable to take their medicines precisely at the deliberate time due to composite psychological and medical issues. The geriatric population needs distinctive care and consideration for the swift recovery from disease or disorder. There is no set age at which patients may be under the care of a geriatrician or geriatric physician. The geriatric physician specifies in the care of geriatric people. The patient care proclamation is determined by the specific patient's needs, as well as the availability of a specialist.

The global geriatric medicines market is majorly driven by the high presence of geriatric populations in many regions. According to the Industry Reports in United Nations 2012, the number of the geriatric population across the globe was approximately 809.4 million and is this anticipated to reach around 1.4 billion by 2030. Moreover, growing chronic conditions and the rising occurrence of chronic disorders such as cardiovascular disorder, rheumatoid arthritis and other bone-related problems, neurological disorders, and cancer cases amongst the geriatric population is another major factor boosting the growth of the geriatric medicines market. Additionally, a number of geriatric population reliant on polypharmacy are anticipated to develop side-effects due to the interactions of the diverse medicines. Which, in turn, has amplified the demand for geriatric care and thus bolstering the geriatric medicines market growth.

The increasing incidences of medication-related disorders among geriatrics and the critical necessity for proper care are the determining factors fueling the market growth. However, the lack of awareness majorly in developing and low-income economies and side effects associated with the medicines are the factors anticipated to binder the market growth.

North America Geriatric Medicines Market Share by Therapeutic Category, 2017 - 2026 (USD Billion)

North America Geriatric Medicines Market Share 2017 - 2026

Inside circle shown for 2017 & outside circle shown for 2026

Segment Analysis

The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography.

On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.

North America Geriatric Medicines Market, by Therapeutic Category, 2017 - 2026 (USD Billion)

North America Geriatric Medicines Market, 2017 - 2026

Regional Analysis

In terms of geography, North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

However, Asia-Pacific, on the other hand, is expected to dominate the global Geriatric Medicines Market during the forecast period. The major market share is primarily due to the substantial growth in the healthcare infrastructure, the launch of the number of branded and generic drugs, an increase in private and government healthcare spending, the increase in per head incomes, and growing number of geriatric population in countries such as Japan, China, and India.

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global Geriatric Medicines Market includes GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

Key questions answered by the report

  • What is the current Market Size and Forecasts of Geriatric Medicines Market?
  • What is the market opportunity for Geriatric Medicines Market?
  • How big is the market size for consulting services for Geriatric Medicines Market?
  • How much is the estimated market for Geriatric Medicines in North America in the forecast period?
  • What are the available opportunities and who are the top market players in this space?
  • Which are the major therapeutic conditions segments and what traction are they gaining in the market?

 

Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-aways
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Geriatric Medicines Market Insights
    1. Geriatric Medicines – Industry snapshot
    2. Geriatric Medicines - Ecosystem analysis
    3. Geriatric Medicines Market dynamics
      1. Geriatric Medicines – Market Forces
        1. Geriatric Medicines Market driver analysis
        2. Geriatric Medicines Market restraint/challenges analysis
        3. Geriatric Medicines Market opportunity analysis
    4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
    5. Geriatric Medicines Market PEST analysis, 2017
      1. Geriatric Medicines Industry trends
      2. Competitive Ranking Analysis
  4. Geriatric Medicines Market Size and Forecast by Therapeutic Category
    1. Key findings
    2. Analgesics
      1. Global market estimates and forecasts, 2017 – 2026
    3. Antihypertensives
      1. Global market estimates and forecasts, 2017 – 2026
    4. Statins
      1. Global market estimates and forecasts, 2017 – 2026
    5. Antidiabetics
      1. Global market estimates and forecasts, 2017 – 2026
    6. Proton Pump Inhibitor
      1. Global market estimates and forecasts, 2017 – 2026
    7. Anticoagulant
      1. Global market estimates and forecasts, 2017 – 2026
    8. Antipsychotic
      1. Global market estimates and forecasts, 2017 – 2026
    9. Antidepressant
      1. Global market estimates and forecasts, 2017 – 2026
  5. Geriatric Medicines Market Size and Forecast by Therapeutic Condition
    1. Key findings
    2. Cardiovascular
      1. Global market estimates and forecasts, 2017 - 2026
    3. Arthritis
      1. Global market estimates and forecasts, 2017 – 2026
    4. Neurological
      1. Global market estimates and forecasts, 2017 – 2026
    5. Cancer
      1. Global market estimates and forecasts, 2017 - 2026
    6. Osteoporosis
      1. Global market estimates and forecasts, 2017 – 2026
    7. Respiratory
      1. Global market estimates and forecasts, 2017 – 2026
  6. Geriatric Medicines Market Size and Forecast by Regions
    1. Key findings
    2. North America
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. U.S.
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. Canada
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
    3. Europe
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. Germany
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. UK
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      5. France
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      6. Italy
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
    4. Asia Pacific
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. China
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. India
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      5. Japan
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      6. Australia
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
    5. Latin America
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. Brazil
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. Mexico
        1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
        2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
    6. Middle East & Africa
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
  7. Company Profiles
    1. GlaxoSmithKline Plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    2. BoehringerIngelheim GmbH
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    3. Novartis AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    4. Bristol-Myers Squibb Company
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    5. Pfizer, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    6. Eli Lilly and Company
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    7. Abbott Laboratories Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
    8. AstraZeneca plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    9. Merck & Company Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    10. Sanofi S.A.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments

 

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecasts from 2017 to 2026
  • Market revenue estimates for Therapeutic Category up to 2026
  • Market revenue estimates for Therapeutic Condition up to 2026
  • Regional market size and forecasts from 2017 to 2026
  • Regional market size and forecast for Therapeutic category up to 2026
  • Regional market size and forecast for Therapeutic Condition up to 2026
  • Company financials

Request For customization

 

By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

 

By using this form you agree with the storage and handling of your data by this website.

Inquire Before Buying

 

By using this form you agree with the storage and handling of your data by this website.

Request for Sample

By using this form you agree with the storage and handling of your data by this website.